You are here

Interdisciplinary Practice Helps Hospitals Improve Collaboration and Outcomes

Smaller hospitals may be better suited to this approach

Interdisciplinary practice may help hospitals with efforts to reduce costs and improve patient outcomes, according to

FierceHealthCare reports that Blythedale Children's Hospital in Valhalla, New York, implemented interdisciplinary training in therapeutic crisis intervention four years ago. Since then it has expanded the effort, with a newly hired chief medical officer and chief nursing officer assembling an interdisciplinary work group to enhance interprofessional communications. The practice is so effective that it is now an inextricable part of Blythedale Children's organizational culture, said Jill Wegener, RN, the hospital's chief nursing officer.

The hospital holds interdisciplinary care plan meetings once a week with representatives from every discipline that has direct contact with the child, she said. The staff members use the meetings to develop multidisciplinary patient care plans that allow each participant a "big picture" view of what other disciplines are doing during the care process.

Thus far, Wegener said, the biggest obstacle to this strategy is potential scheduling conflicts. If and when these occur, she said, the teams meet for brief huddles to reach a consensus instead. Part of why the interdisciplinary approach works, she said, is because Blythedale Children's is a smaller hospital with fewer bureaucratic layers.

California hospitals, preparing for an influx of senior citizen patients as the population ages, have also made use of interdisciplinary teams, developing them to treat elderly patients with complex needs, FierceHealthcare previously reported.

Source: FierceHealthcare, November 23, 2015.

Recent Headlines

WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs